▶ 調査レポート

世界のノロウイルス診断市場

• 英文タイトル:Market Study on Norovirus Diagnostics: Over Half Market Share Held by Diagnostic Laboratories

Market Study on Norovirus Diagnostics: Over Half Market Share Held by Diagnostic Laboratories「世界のノロウイルス診断市場」(市場規模、市場予測)調査レポートです。• レポートコード:PMR2201A033
• 出版社/出版日:Persistence Market Research / 2021年10月11日
• レポート形態:英文、PDF、245ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥622,300 (USD4,900)▷ お問い合わせ
  Site Licence¥965,200 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,346,200 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートは、世界のノロウイルス診断市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、新型コロナウイルス感染症の危機分析、主要成功要因、市場需要分析/予測、価格分析、製品別(迅速検査キット、PCRキット、ELISAベースキット)分析、エンドユーザー別(病院、診断研究所、研究機関、バイオ医薬品企業)分析、地域別分析、主要国分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・市場背景
・新型コロナウイルス感染症の危機分析
・主要成功要因
・市場需要分析/予測
・価格分析
・世界のノロウイルス診断市場規模:製品別(迅速検査キット、PCRキット、ELISAベースキット)
・世界のノロウイルス診断市場規模:エンドユーザー別(病院、診断研究所、研究機関、バイオ医薬品企業)
・世界のノロウイルス診断市場規模:地域別
・主要国分析
・市場構造分析
・競争分析
・仮定
・調査手法

Norovirus Diagnostics Market – Scope of Report

The latest publication by Persistence Market Research on the global norovirus diagnostics market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market.

The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for norovirus diagnostics products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the norovirus diagnostics market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the norovirus diagnostics market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the norovirus diagnostics market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments
Persistence Market Research’s study on the norovirus diagnostics market offers information divided into 3 important segments – product, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product
Rapid Test Kits
PCR Kits
ELISA-based kits

End User
Hospitals
Diagnostics Labs
Clinics

Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for norovirus diagnostics over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies involved in norovirus diagnostics avail the growth opportunities in developed and emerging sectors?

Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the norovirus diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the norovirus diagnostics market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Latest Market Consolidation Activities

4. Market Background

4.1. Macro-Economic Factors

4.1.1. Global GDP Growth Outlook

4.1.2. Global Healthcare Expenditure Outlook

4.1.3. Parent Market Outlook

4.2. Forecast Factors – Relevance & Impact

4.2.1. Rising prevalence of Norovirus

4.2.2. Increasing Demand for Rapid Testing

4.2.3. Technological Advancement

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Trends

4.3.4. Opportunity Analysis

5. COVID19 Crisis Analysis

5.1. Current COVID19 Probable Future Impact

5.2. Current GDP Projection and Probable Impact

5.3. COVID19 and Impact Analysis

5.3.1. Revenue by Product

5.3.2. Revenue by End User

5.3.3. Revenue By Region

5.4. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Key Success Factors

6.1. Adoption / Usage Analysis

6.2. New product launches

6.3. Key regulations

6.4. Key Products USP Analysis

6.5. PESTLE Analysis

6.6. Porters Analysis

6.7. Value Chain analysis

6.8. Key Manufacturers Promotional Strategies Strategic

7. Global Norovirus Diagnostics Market Demand (in Volume ‘000 Units) Analysis 2016-2020 and Forecast, 2021–2031

7.1. Historical Market Volume (‘000 Units) Analysis, 2016-2020

7.2. Current and Future Market Volume (‘000 Units) Projections, 2021-2031

7.2.1. Y-o-Y Growth Trend Analysis

8. Global Norovirus Diagnostics Market- Pricing Analysis

8.1. Regional Pricing Analysis, By Product

8.2. Pricing Break-up

8.2.1. Manufacturer Level Pricing

8.2.2. Distributor Level Pricing

8.3. Global Average Pricing Analysis Benchmark

9. Global Norovirus Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

9.2. Current and Future Market Value (In Value or Size in US$ Mn) Projections, 2021-2031

9.2.1. Y-o-Y Growth Trend Analysis

9.2.2. Absolute $ Opportunity Analysis

10. Global Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, By Product

10.1. Introduction / Key Findings

10.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend By Product, 2016-2020

10.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units)Trend Analysis and Forecast By Product, 2021-2031

10.3.1. Rapid test kits

10.3.2. PCR kits

10.3.3. ELISA based kits

10.4. Market Attractiveness Analysis By Product

11. Global Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, By End User

11.1. Introduction / Key Findings

11.2. Historical Market Size (In Value or Size in US$ Mn) Trend By End User, 2016-2020

11.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast By End User , 2021-2031

11.3.1. Hospitals

11.3.2. Diagnostic Laboratories

11.3.3. Research Institutes

11.3.4. Biopharmaceutical Companies.

11.4. Market Attractiveness Analysis By End User

12. Global Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Region

12.1. Introduction

12.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Analysis By Region, 2016 – 2020

12.3. Current Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Analysis and Forecast By Region, 2021 – 2031

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. South Asia

12.3.5. East Asia

12.3.6. Oceania

12.3.7. Middle East and Africa (MEA)

12.4. Market Attractiveness Analysis By Region

13. North America Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

13.1. Introduction

13.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020

13.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis Forecast By Market Taxonomy, 2021-2031

13.3.1. By Country

13.3.1.1. U.S.

13.3.1.2. Canada

13.3.2. By Product

13.3.3. By End User

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Latin America Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

14.1. Introduction

14.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016 – 2020

14.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis Forecast By Market Taxonomy, 2021-2031

14.3.1. By Country

14.3.1.1. Brazil

14.3.1.2. Mexico

14.3.1.3. Argentina

14.3.1.4. Rest of Latin America

14.3.2. By Product

14.3.3. By End User

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. Europe Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

15.1. Introduction

15.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020

15.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis Forecast By Market Taxonomy 2021-2031

15.3.1. By Country

15.3.1.1. Germany

15.3.1.2. Italy

15.3.1.3. France

15.3.1.4. U.K.

15.3.1.5. Spain

15.3.1.6. BENELUX

15.3.1.7. Russia

15.3.1.8. Rest of Europe

15.3.2. By Product

15.3.3. By End User

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. South Asia Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

16.1. Introduction

16.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020

16.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy 2021-2031

16.3.1. By Country

16.3.1.1. India

16.3.1.2. Thailand

16.3.1.3. Indonesia

16.3.1.4. Malaysia

16.3.1.5. Rest of South Asia

16.3.2. By Product

16.3.3. By End User

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. East Asia Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

17.1. Introduction

17.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020

17.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2021-2031

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.2. By Product

17.3.3. By End User

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Oceania Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

18.1. Introduction

18.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020

18.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2021-2031

18.3.1. By Country

18.3.1.1. Australia

18.3.1.2. New Zealand

18.3.2. By Product

18.3.3. By End User

18.4. Market Attractiveness Analysis

18.5. Key Market Participants – Intensity Mapping

18.6. Drivers and Restraints – Impact Analysis

19. Middle East and Africa Norovirus Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

19.1. Introduction

19.2. Historical Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2016-2020

19.3. Current and Future Market Size (In Value or Size in US$ Mn) and Volume (in ‘000 Units) Trend Analysis By Market Taxonomy, 2021-2031

19.3.1. By Country

19.3.1.1. GCC Countries

19.3.1.2. Turkey

19.3.1.3. South Africa

19.3.1.4. Rest of Middle East and Africa

19.3.2. By Product

19.3.3. By End User

19.4. Market Attractiveness Analysis

19.5. Key Market Participants – Intensity Mapping

19.6. Drivers and Restraints – Impact Analysis

20. Key Countries Norovirus Diagnostics Market Analysis 2021 & 2031

20.1. U.S. Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.1.1. By Product

20.1.2. By End User

20.2. Canada Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.2.1. By Product

20.2.2. By End User

20.3. Brazil Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.3.1. By Product

20.3.2. By End User

20.4. Mexico Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.4.1. By Product

20.4.2. By End User

20.5. Argentina Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.5.1. By Product

20.5.2. By End User

20.6. U.K. Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.6.1. By Product

20.6.2. By End User

20.7. Germany Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.7.1. By Product

20.7.2. By End User

20.8. France Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.8.1. By Product

20.8.2. By End User

20.9. Italy Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.9.1. By Product

20.9.2. By End User

20.10. Spain Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.10.1. By Product

20.10.2. By End User

20.11. BENELUX Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.11.1. By Product

20.11.2. By End User

20.12. Russia Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.12.1. By Product

20.12.2. By End User

20.13. India Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.13.1. By Product

20.13.2. By End User

20.14. ASEAN Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.14.1. By Product

20.14.2. By End User

20.15. Japan Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.15.1. By Product

20.15.2. By End User

20.16. China Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.16.1. By Product

20.16.2. By End User

20.17. South Korea Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.17.1. By Product

20.17.2. By End User

20.18. Australia Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.18.1. By Product

20.18.2. By End User

20.19. New Zealand Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.19.1. By Product

20.19.2. By End User

20.20. GCC Countries Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.20.1. By Product

20.20.2. By End User

20.21. Turkey Norovirus Diagnostics Market Value (US$) Analysis, 2021 & 2031

20.21.1. By Product

20.21.2. By End User

20.22. South Africa Norovirus Diagnostics Market Value (US$) and Analysis, 2021 & 2031

20.22.1. By Product

20.22.2. By End User

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies

21.2. Market Concentration

21.3. Market Share Analysis of Top Players

21.4. Market Presence Analysis

21.4.1.1. Regional footprint of Players

21.4.1.2. Method foot print by Players

21.4.1.3. Channel Foot Print by Players

22. Competition Analysis

22.1. Competition Dashboard

22.2. Competition Benchmarking

22.3. Competition Deep Dive

22.3.1. Abbott

22.3.1.1. Overview

22.3.1.2. Product Portfolio

22.3.1.3. Profitability by Market Segments (Product/End User/Region)

22.3.1.4. Sales Footprint

22.3.1.5. Strategy Overview

22.3.1.5.1. Marketing Strategy

22.3.1.5.2. Product Strategy

22.3.1.5.3. End User Strategy

22.3.2. R-Biopharm AG

22.3.2.1. Overview

22.3.2.2. Product Portfolio

22.3.2.3. Profitability by Market Segments (Product/End User/Region)

22.3.2.4. Sales Footprint

22.3.2.5. Strategy Overview

22.3.2.5.1. Marketing Strategy

22.3.2.5.2. Product Strategy

22.3.2.5.3. End User Strategy

22.3.3. Cepheid

22.3.3.1. Overview

22.3.3.2. Product Portfolio

22.3.3.3. Profitability by Market Segments (Product/End User/Region)

22.3.3.4. Sales Footprint

22.3.3.5. Strategy Overview

22.3.3.5.1. Marketing Strategy

22.3.3.5.2. Product Strategy

22.3.3.5.3. End User Strategy

22.3.4. Luminex Corporation

22.3.4.1. Overview

22.3.4.2. Product Portfolio

22.3.4.3. Profitability by Market Segments (Product/End User/Region)

22.3.4.4. Sales Footprint

22.3.4.5. Strategy Overview

22.3.4.5.1. Marketing Strategy

22.3.4.5.2. Product Strategy

22.3.4.5.3. End User Strategy

22.3.5. Meridian Bioscience

22.3.5.1. Overview

22.3.5.2. Product Portfolio

22.3.5.3. Profitability by Market Segments (Product/End User/Region)

22.3.5.4. Sales Footprint

22.3.5.5. Strategy Overview

22.3.5.5.1. Marketing Strategy

22.3.5.5.2. Product Strategy

22.3.5.5.3. End User Strategy

22.3.6. ELITechGroup

22.3.6.1. Overview

22.3.6.2. Product Portfolio

22.3.6.3. Profitability by Market Segments (Product/End User/Region)

22.3.6.4. Sales Footprint

22.3.6.5. Strategy Overview

22.3.6.5.1. Marketing Strategy

22.3.6.5.2. Product Strategy

22.3.6.5.3. End User Strategy

22.3.7. Biomérieux SA

22.3.7.1. Overview

22.3.7.2. Product Portfolio

22.3.7.3. Profitability by Market Segments (Product/End User/Region)

22.3.7.4. Sales Footprint

22.3.7.5. Strategy Overview

22.3.7.5.1. Marketing Strategy

22.3.7.5.2. Product Strategy

22.3.7.5.3. End User Strategy

22.3.8. CerTest Biotec S.L.

22.3.8.1. Overview

22.3.8.2. Product Portfolio

22.3.8.3. Profitability by Market Segments (Product/End User/Region)

22.3.8.4. Sales Footprint

22.3.8.5. Strategy Overview

22.3.8.5.1. Marketing Strategy

22.3.8.5.2. Product Strategy

22.3.8.5.3. End User Strategy

22.3.9. Elisabeth Pharmacon, Spol. S Ro

22.3.9.1. Overview

22.3.9.2. Product Portfolio

22.3.9.3. Profitability by Market Segments (Product/End User/Region)

22.3.9.4. Sales Footprint

22.3.9.5. Strategy Overview

22.3.9.5.1. Marketing Strategy

22.3.9.5.2. Product Strategy

22.3.9.5.3. End User Strategy

22.3.10. Qiagen

22.3.10.1. Overview

22.3.10.2. Product Portfolio

22.3.10.3. Profitability by Market Segments (Product/End User/Region)

22.3.10.4. Sales Footprint

22.3.10.5. Strategy Overview

22.3.10.5.1. Marketing Strategy

22.3.10.5.2. Product Strategy

22.3.10.5.3. End User Strategy

22.3.11. Altona Diagnostics GmbH

22.3.11.1. Overview

22.3.11.2. Product Portfolio

22.3.11.3. Profitability by Market Segments (Product/End User/Region)

22.3.11.4. Sales Footprint

22.3.11.5. Strategy Overview

22.3.11.5.1. Marketing Strategy

22.3.11.5.2. Product Strategy

22.3.11.5.3. End User Strategy

22.3.12. Eiken Chemical Co.

22.3.12.1. Overview

22.3.12.2. Product Portfolio

22.3.12.3. Profitability by Market Segments (Product/End User/Region)

22.3.12.4. Sales Footprint

22.3.12.5. Strategy Overview

22.3.12.5.1. Marketing Strategy

22.3.12.5.2. Product Strategy

22.3.12.5.3. End User Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Table 01: Global Norovirus Infection Diagnostics Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 02: Global Norovirus Infection Diagnostics Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 03: Global Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 04: Global Norovirus Infection Diagnostics Market volume (‘000 units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 05: Global Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 06: Global Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 07: Global Norovirus Infection Diagnostics Market Volume (‘000 units) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 08: North America Perfusion Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 09: North America Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 10: North America Norovirus Infection Diagnostics Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 11: North America Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 12: Latin America Perfusion Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 13: Latin America Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 14: Latin America Norovirus Infection Diagnostics Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 15: Latin America Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 16: Europe Perfusion Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 17: Europe Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 18: Europe Norovirus Infection Diagnostics Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 19: Europe Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 20: South Asia Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 21: South Asia Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 22: South Asia Norovirus Infection Diagnostics Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 23: South Asia Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 24: East Asia Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 25: East Asia Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 26: East Asia Norovirus Infection Diagnostics Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 27: East Asia Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 28: Oceania Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 29: Oceania Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 30: Oceania Norovirus Infection Diagnostics Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 31: Oceania Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User

Table 32: MEA Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 33: MEA Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 34: MEA Norovirus Infection Diagnostics Market Volume (in '000 Units) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 35: MEA Norovirus Infection Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, by End User